000 | 01461 a2200445 4500 | ||
---|---|---|---|
005 | 20250516101756.0 | ||
264 | 0 | _c20130205 | |
008 | 201302s 0 0 eng d | ||
022 | _a0392-856X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTurkstra, F | |
245 | 0 | 0 |
_aResults of a questionnaire on the treatment of patients with Behçet's syndrome: a trend for more intensive treatment. _h[electronic resource] |
260 |
_bClinical and experimental rheumatology _c |
||
300 |
_aS10-3 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
650 | 0 | 4 |
_aBehcet Syndrome _xcomplications |
650 | 0 | 4 | _aConsensus |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aEvidence-Based Medicine |
650 | 0 | 4 | _aGuideline Adherence |
650 | 0 | 4 | _aHealth Care Surveys |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 | _aPractice Patterns, Physicians' |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSex Factors |
650 | 0 | 4 | _aSurveys and Questionnaires |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _avan Vugt, R M | |
700 | 1 | _aDijkmans, B A C | |
700 | 1 | _aYazici, Y | |
700 | 1 | _aYazici, H | |
773 | 0 |
_tClinical and experimental rheumatology _gvol. 30 _gno. 3 Suppl 72 _gp. S10-3 |
|
999 |
_c21929052 _d21929052 |